Ikena Oncology, Inc. (IKNA) Social Stream
IKENA ONCOLOGY INC (IKNA) Price Targets From Analysts
Use the tables below to see what analysts covering IKENA ONCOLOGY INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-18 | 3 | $27 | $27 | $27 | $1.88 | 1336.17% |
| 2022-04-12 | 4 | $27 | $25 | $26 | $1.88 | 1282.98% |
| 2022-11-18 | 4 | $27 | $26 | $26.5 | $1.88 | 1309.57% |
| 2022-11-29 | 3 | $27 | $22 | $24.5 | $1.88 | 1203.19% |
| 2023-03-17 | 4 | $27 | $22 | $24.5 | $1.88 | 1203.19% |
| 2023-03-19 | 4 | $22 | $22 | $22 | $1.88 | 1070.21% |
| 2023-08-10 | 5 | $22 | $18 | $20 | $1.88 | 963.83% |
| 2023-09-22 | 5 | $22 | $11 | $17 | $1.88 | 804.26% |
| 2023-11-09 | 5 | $11 | $6 | $8.333 | $1.88 | 343.24% |
The Trend in the Analyst Price Target
IKNA's average price target has moved down $20.17 over the prior 31 months.
IKNA reports an average of 338.81% for its upside potential over the past 34 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-15 | 4 | 22 | 18 | 20.000 | 7.00 | 185.71% |
| 2023-08-10 | 5 | 22 | 18 | 20.000 | 4.54 | 340.53% |
| 2023-08-10 | 4 | 22 | 18 | 20.000 | 4.54 | 340.53% |
| 2023-09-22 | 5 | 22 | 11 | 17.000 | 4.56 | 272.81% |
| 2023-11-09 | 5 | 11 | 6 | 8.333 | 1.33 | 526.54% |
IKNA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
IKNA's average broker recommendation rating improved by 0 over the prior 26 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IKNA as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, IKENA ONCOLOGY INC's upside potential (average analyst target price relative to current price) is greater than 1066.37% of them.
- To contextualize these metrics, consider that out of all US stocks, IKENA ONCOLOGY INC's variance in analysts' estimates is lower than -119.17% of them.
- IKNA has a greater number of analysts covering the stock than 189.35% of Healthcare stocks.
- In terms of how IKENA ONCOLOGY INC fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 630.24% of that group.
In the Pharmaceutical Products industry, ACHL, MOLN, and IPSC are the three stocks most similar to IKENA ONCOLOGY INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is IKNA a Buy, Hold or Sell? See the POWR Ratings now!